What Researchers Did
Researchers reviewed the historical use and current rational applications of hyperbaric oxygen therapy (HBOT) in medical treatment.
What They Found
They found that hyperbaric oxygen therapy (HBOT) enhances wound healing, suppresses infection, reduces edema, and reverses central nervous system damage from carbon monoxide and cyanide poisoning. HBOT also reduces clostridial alpha toxins, with specific indications recognized by the Undersea and Hyperbaric Medicine Society and most third-party payers.
What This Means for Canadian Patients
Canadian patients with specific conditions such as non-healing wounds, certain infections, or carbon monoxide poisoning may benefit from hyperbaric oxygen therapy (HBOT). Access to HBOT in Canada would likely follow established protocols and recognized indications, similar to those outlined by international societies.
Canadian Relevance
This study has no direct Canadian connection as it does not involve Canadian researchers, patients, or healthcare systems.
Study Limitations
As a review, this study does not present new primary research data or specific patient outcomes, and some potential applications of HBOT remain investigational.